Medical Care
Global Companion Animal Drugs Market Research Report 2024
- Jan 20, 24
- ID: 19857
- Pages: 87
- Figures: 173
- Views: 20
The global Companion Animal Drugs market was valued at US$ 26770 million in 2023 and is anticipated to reach US$ 33550 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.
This report aims to provide a comprehensive presentation of the global market for Companion Animal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Drugs.
Report Scope
The Companion Animal Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Animal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Animal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Bayer
Boehringer Ingelheim
Eli Lilly
Merck
Vetoquinol
Virbac
Dechra Pharmaceuticals
Ceva Sante Animale
Aratana Therapeutics
Segment by Type
Antibiotics and Antimicrobials
Parasiticides
Others
Segment by Application
Dogs
Cats
Horses
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Animal Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.
This report aims to provide a comprehensive presentation of the global market for Companion Animal Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Animal Drugs.
Report Scope
The Companion Animal Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Animal Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Companion Animal Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Bayer
Boehringer Ingelheim
Eli Lilly
Merck
Vetoquinol
Virbac
Dechra Pharmaceuticals
Ceva Sante Animale
Aratana Therapeutics
Segment by Type
Antibiotics and Antimicrobials
Parasiticides
Others
Segment by Application
Dogs
Cats
Horses
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Animal Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animal Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibiotics and Antimicrobials
1.2.3 Parasiticides
1.2.4 Others
1.3 Market by Application
1.3.1 Global Companion Animal Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Horses
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Animal Drugs Market Perspective (2019-2030)
2.2 Companion Animal Drugs Growth Trends by Region
2.2.1 Global Companion Animal Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Animal Drugs Historic Market Size by Region (2019-2024)
2.2.3 Companion Animal Drugs Forecasted Market Size by Region (2025-2030)
2.3 Companion Animal Drugs Market Dynamics
2.3.1 Companion Animal Drugs Industry Trends
2.3.2 Companion Animal Drugs Market Drivers
2.3.3 Companion Animal Drugs Market Challenges
2.3.4 Companion Animal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animal Drugs Players by Revenue
3.1.1 Global Top Companion Animal Drugs Players by Revenue (2019-2024)
3.1.2 Global Companion Animal Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Companion Animal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Animal Drugs Revenue
3.4 Global Companion Animal Drugs Market Concentration Ratio
3.4.1 Global Companion Animal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Drugs Revenue in 2023
3.5 Companion Animal Drugs Key Players Head office and Area Served
3.6 Key Players Companion Animal Drugs Product Solution and Service
3.7 Date of Enter into Companion Animal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animal Drugs Breakdown Data by Type
4.1 Global Companion Animal Drugs Historic Market Size by Type (2019-2024)
4.2 Global Companion Animal Drugs Forecasted Market Size by Type (2025-2030)
5 Companion Animal Drugs Breakdown Data by Application
5.1 Global Companion Animal Drugs Historic Market Size by Application (2019-2024)
5.2 Global Companion Animal Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Animal Drugs Market Size (2019-2030)
6.2 North America Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Animal Drugs Market Size by Country (2019-2024)
6.4 North America Companion Animal Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Animal Drugs Market Size (2019-2030)
7.2 Europe Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Animal Drugs Market Size by Country (2019-2024)
7.4 Europe Companion Animal Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Drugs Market Size (2019-2030)
8.2 Asia-Pacific Companion Animal Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Animal Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Animal Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Animal Drugs Market Size (2019-2030)
9.2 Latin America Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Animal Drugs Market Size by Country (2019-2024)
9.4 Latin America Companion Animal Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Drugs Market Size (2019-2030)
10.2 Middle East & Africa Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Animal Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Animal Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animal Drugs Introduction
11.1.4 Zoetis Revenue in Companion Animal Drugs Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Companion Animal Drugs Introduction
11.2.4 Bayer Revenue in Companion Animal Drugs Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Companion Animal Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Companion Animal Drugs Introduction
11.4.4 Eli Lilly Revenue in Companion Animal Drugs Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Companion Animal Drugs Introduction
11.5.4 Merck Revenue in Companion Animal Drugs Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Vetoquinol
11.6.1 Vetoquinol Company Detail
11.6.2 Vetoquinol Business Overview
11.6.3 Vetoquinol Companion Animal Drugs Introduction
11.6.4 Vetoquinol Revenue in Companion Animal Drugs Business (2019-2024)
11.6.5 Vetoquinol Recent Development
11.7 Virbac
11.7.1 Virbac Company Detail
11.7.2 Virbac Business Overview
11.7.3 Virbac Companion Animal Drugs Introduction
11.7.4 Virbac Revenue in Companion Animal Drugs Business (2019-2024)
11.7.5 Virbac Recent Development
11.8 Dechra Pharmaceuticals
11.8.1 Dechra Pharmaceuticals Company Detail
11.8.2 Dechra Pharmaceuticals Business Overview
11.8.3 Dechra Pharmaceuticals Companion Animal Drugs Introduction
11.8.4 Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2019-2024)
11.8.5 Dechra Pharmaceuticals Recent Development
11.9 Ceva Sante Animale
11.9.1 Ceva Sante Animale Company Detail
11.9.2 Ceva Sante Animale Business Overview
11.9.3 Ceva Sante Animale Companion Animal Drugs Introduction
11.9.4 Ceva Sante Animale Revenue in Companion Animal Drugs Business (2019-2024)
11.9.5 Ceva Sante Animale Recent Development
11.10 Aratana Therapeutics
11.10.1 Aratana Therapeutics Company Detail
11.10.2 Aratana Therapeutics Business Overview
11.10.3 Aratana Therapeutics Companion Animal Drugs Introduction
11.10.4 Aratana Therapeutics Revenue in Companion Animal Drugs Business (2019-2024)
11.10.5 Aratana Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Animal Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibiotics and Antimicrobials
1.2.3 Parasiticides
1.2.4 Others
1.3 Market by Application
1.3.1 Global Companion Animal Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Horses
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Animal Drugs Market Perspective (2019-2030)
2.2 Companion Animal Drugs Growth Trends by Region
2.2.1 Global Companion Animal Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Animal Drugs Historic Market Size by Region (2019-2024)
2.2.3 Companion Animal Drugs Forecasted Market Size by Region (2025-2030)
2.3 Companion Animal Drugs Market Dynamics
2.3.1 Companion Animal Drugs Industry Trends
2.3.2 Companion Animal Drugs Market Drivers
2.3.3 Companion Animal Drugs Market Challenges
2.3.4 Companion Animal Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Animal Drugs Players by Revenue
3.1.1 Global Top Companion Animal Drugs Players by Revenue (2019-2024)
3.1.2 Global Companion Animal Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Companion Animal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Animal Drugs Revenue
3.4 Global Companion Animal Drugs Market Concentration Ratio
3.4.1 Global Companion Animal Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Animal Drugs Revenue in 2023
3.5 Companion Animal Drugs Key Players Head office and Area Served
3.6 Key Players Companion Animal Drugs Product Solution and Service
3.7 Date of Enter into Companion Animal Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Animal Drugs Breakdown Data by Type
4.1 Global Companion Animal Drugs Historic Market Size by Type (2019-2024)
4.2 Global Companion Animal Drugs Forecasted Market Size by Type (2025-2030)
5 Companion Animal Drugs Breakdown Data by Application
5.1 Global Companion Animal Drugs Historic Market Size by Application (2019-2024)
5.2 Global Companion Animal Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Animal Drugs Market Size (2019-2030)
6.2 North America Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Animal Drugs Market Size by Country (2019-2024)
6.4 North America Companion Animal Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Animal Drugs Market Size (2019-2030)
7.2 Europe Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Animal Drugs Market Size by Country (2019-2024)
7.4 Europe Companion Animal Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Drugs Market Size (2019-2030)
8.2 Asia-Pacific Companion Animal Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Animal Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Animal Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Animal Drugs Market Size (2019-2030)
9.2 Latin America Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Animal Drugs Market Size by Country (2019-2024)
9.4 Latin America Companion Animal Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Drugs Market Size (2019-2030)
10.2 Middle East & Africa Companion Animal Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Animal Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Animal Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Companion Animal Drugs Introduction
11.1.4 Zoetis Revenue in Companion Animal Drugs Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Companion Animal Drugs Introduction
11.2.4 Bayer Revenue in Companion Animal Drugs Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Companion Animal Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2019-2024)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Companion Animal Drugs Introduction
11.4.4 Eli Lilly Revenue in Companion Animal Drugs Business (2019-2024)
11.4.5 Eli Lilly Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Companion Animal Drugs Introduction
11.5.4 Merck Revenue in Companion Animal Drugs Business (2019-2024)
11.5.5 Merck Recent Development
11.6 Vetoquinol
11.6.1 Vetoquinol Company Detail
11.6.2 Vetoquinol Business Overview
11.6.3 Vetoquinol Companion Animal Drugs Introduction
11.6.4 Vetoquinol Revenue in Companion Animal Drugs Business (2019-2024)
11.6.5 Vetoquinol Recent Development
11.7 Virbac
11.7.1 Virbac Company Detail
11.7.2 Virbac Business Overview
11.7.3 Virbac Companion Animal Drugs Introduction
11.7.4 Virbac Revenue in Companion Animal Drugs Business (2019-2024)
11.7.5 Virbac Recent Development
11.8 Dechra Pharmaceuticals
11.8.1 Dechra Pharmaceuticals Company Detail
11.8.2 Dechra Pharmaceuticals Business Overview
11.8.3 Dechra Pharmaceuticals Companion Animal Drugs Introduction
11.8.4 Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2019-2024)
11.8.5 Dechra Pharmaceuticals Recent Development
11.9 Ceva Sante Animale
11.9.1 Ceva Sante Animale Company Detail
11.9.2 Ceva Sante Animale Business Overview
11.9.3 Ceva Sante Animale Companion Animal Drugs Introduction
11.9.4 Ceva Sante Animale Revenue in Companion Animal Drugs Business (2019-2024)
11.9.5 Ceva Sante Animale Recent Development
11.10 Aratana Therapeutics
11.10.1 Aratana Therapeutics Company Detail
11.10.2 Aratana Therapeutics Business Overview
11.10.3 Aratana Therapeutics Companion Animal Drugs Introduction
11.10.4 Aratana Therapeutics Revenue in Companion Animal Drugs Business (2019-2024)
11.10.5 Aratana Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Companion Animal Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibiotics and Antimicrobials
Table 3. Key Players of Parasiticides
Table 4. Key Players of Others
Table 5. Global Companion Animal Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Companion Animal Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Companion Animal Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Companion Animal Drugs Market Share by Region (2019-2024)
Table 9. Global Companion Animal Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Companion Animal Drugs Market Share by Region (2025-2030)
Table 11. Companion Animal Drugs Market Trends
Table 12. Companion Animal Drugs Market Drivers
Table 13. Companion Animal Drugs Market Challenges
Table 14. Companion Animal Drugs Market Restraints
Table 15. Global Companion Animal Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Companion Animal Drugs Market Share by Players (2019-2024)
Table 17. Global Top Companion Animal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Drugs as of 2023)
Table 18. Ranking of Global Top Companion Animal Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Companion Animal Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Companion Animal Drugs Product Solution and Service
Table 22. Date of Enter into Companion Animal Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Companion Animal Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Companion Animal Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Companion Animal Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Companion Animal Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Companion Animal Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Companion Animal Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Companion Animal Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Companion Animal Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Companion Animal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Companion Animal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Companion Animal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Companion Animal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Companion Animal Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Companion Animal Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Companion Animal Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Companion Animal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Companion Animal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Companion Animal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Companion Animal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Zoetis Company Detail
Table 48. Zoetis Business Overview
Table 49. Zoetis Companion Animal Drugs Product
Table 50. Zoetis Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 51. Zoetis Recent Development
Table 52. Bayer Company Detail
Table 53. Bayer Business Overview
Table 54. Bayer Companion Animal Drugs Product
Table 55. Bayer Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 56. Bayer Recent Development
Table 57. Boehringer Ingelheim Company Detail
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Companion Animal Drugs Product
Table 60. Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Eli Lilly Company Detail
Table 63. Eli Lilly Business Overview
Table 64. Eli Lilly Companion Animal Drugs Product
Table 65. Eli Lilly Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 66. Eli Lilly Recent Development
Table 67. Merck Company Detail
Table 68. Merck Business Overview
Table 69. Merck Companion Animal Drugs Product
Table 70. Merck Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Vetoquinol Company Detail
Table 73. Vetoquinol Business Overview
Table 74. Vetoquinol Companion Animal Drugs Product
Table 75. Vetoquinol Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 76. Vetoquinol Recent Development
Table 77. Virbac Company Detail
Table 78. Virbac Business Overview
Table 79. Virbac Companion Animal Drugs Product
Table 80. Virbac Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 81. Virbac Recent Development
Table 82. Dechra Pharmaceuticals Company Detail
Table 83. Dechra Pharmaceuticals Business Overview
Table 84. Dechra Pharmaceuticals Companion Animal Drugs Product
Table 85. Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 86. Dechra Pharmaceuticals Recent Development
Table 87. Ceva Sante Animale Company Detail
Table 88. Ceva Sante Animale Business Overview
Table 89. Ceva Sante Animale Companion Animal Drugs Product
Table 90. Ceva Sante Animale Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 91. Ceva Sante Animale Recent Development
Table 92. Aratana Therapeutics Company Detail
Table 93. Aratana Therapeutics Business Overview
Table 94. Aratana Therapeutics Companion Animal Drugs Product
Table 95. Aratana Therapeutics Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 96. Aratana Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Animal Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Companion Animal Drugs Market Share by Type: 2023 VS 2030
Figure 3. Antibiotics and Antimicrobials Features
Figure 4. Parasiticides Features
Figure 5. Others Features
Figure 6. Global Companion Animal Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Companion Animal Drugs Market Share by Application: 2023 VS 2030
Figure 8. Dogs Case Studies
Figure 9. Cats Case Studies
Figure 10. Horses Case Studies
Figure 11. Others Case Studies
Figure 12. Companion Animal Drugs Report Years Considered
Figure 13. Global Companion Animal Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Companion Animal Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Companion Animal Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Companion Animal Drugs Market Share by Players in 2023
Figure 17. Global Top Companion Animal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Companion Animal Drugs Revenue in 2023
Figure 19. North America Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Companion Animal Drugs Market Share by Country (2019-2030)
Figure 21. United States Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Companion Animal Drugs Market Share by Country (2019-2030)
Figure 25. Germany Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Companion Animal Drugs Market Share by Region (2019-2030)
Figure 33. China Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Companion Animal Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Companion Animal Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Zoetis Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 48. Bayer Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 50. Eli Lilly Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 52. Vetoquinol Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 53. Virbac Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 54. Dechra Pharmaceuticals Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 55. Ceva Sante Animale Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 56. Aratana Therapeutics Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Companion Animal Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibiotics and Antimicrobials
Table 3. Key Players of Parasiticides
Table 4. Key Players of Others
Table 5. Global Companion Animal Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Companion Animal Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Companion Animal Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Companion Animal Drugs Market Share by Region (2019-2024)
Table 9. Global Companion Animal Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Companion Animal Drugs Market Share by Region (2025-2030)
Table 11. Companion Animal Drugs Market Trends
Table 12. Companion Animal Drugs Market Drivers
Table 13. Companion Animal Drugs Market Challenges
Table 14. Companion Animal Drugs Market Restraints
Table 15. Global Companion Animal Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Companion Animal Drugs Market Share by Players (2019-2024)
Table 17. Global Top Companion Animal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Drugs as of 2023)
Table 18. Ranking of Global Top Companion Animal Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Companion Animal Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Companion Animal Drugs Product Solution and Service
Table 22. Date of Enter into Companion Animal Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Companion Animal Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Companion Animal Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Companion Animal Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Companion Animal Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Companion Animal Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Companion Animal Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Companion Animal Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Companion Animal Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Companion Animal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Companion Animal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Companion Animal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Companion Animal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Companion Animal Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Companion Animal Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Companion Animal Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Companion Animal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Companion Animal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Companion Animal Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Companion Animal Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Companion Animal Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Zoetis Company Detail
Table 48. Zoetis Business Overview
Table 49. Zoetis Companion Animal Drugs Product
Table 50. Zoetis Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 51. Zoetis Recent Development
Table 52. Bayer Company Detail
Table 53. Bayer Business Overview
Table 54. Bayer Companion Animal Drugs Product
Table 55. Bayer Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 56. Bayer Recent Development
Table 57. Boehringer Ingelheim Company Detail
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Companion Animal Drugs Product
Table 60. Boehringer Ingelheim Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Eli Lilly Company Detail
Table 63. Eli Lilly Business Overview
Table 64. Eli Lilly Companion Animal Drugs Product
Table 65. Eli Lilly Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 66. Eli Lilly Recent Development
Table 67. Merck Company Detail
Table 68. Merck Business Overview
Table 69. Merck Companion Animal Drugs Product
Table 70. Merck Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Vetoquinol Company Detail
Table 73. Vetoquinol Business Overview
Table 74. Vetoquinol Companion Animal Drugs Product
Table 75. Vetoquinol Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 76. Vetoquinol Recent Development
Table 77. Virbac Company Detail
Table 78. Virbac Business Overview
Table 79. Virbac Companion Animal Drugs Product
Table 80. Virbac Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 81. Virbac Recent Development
Table 82. Dechra Pharmaceuticals Company Detail
Table 83. Dechra Pharmaceuticals Business Overview
Table 84. Dechra Pharmaceuticals Companion Animal Drugs Product
Table 85. Dechra Pharmaceuticals Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 86. Dechra Pharmaceuticals Recent Development
Table 87. Ceva Sante Animale Company Detail
Table 88. Ceva Sante Animale Business Overview
Table 89. Ceva Sante Animale Companion Animal Drugs Product
Table 90. Ceva Sante Animale Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 91. Ceva Sante Animale Recent Development
Table 92. Aratana Therapeutics Company Detail
Table 93. Aratana Therapeutics Business Overview
Table 94. Aratana Therapeutics Companion Animal Drugs Product
Table 95. Aratana Therapeutics Revenue in Companion Animal Drugs Business (2019-2024) & (US$ Million)
Table 96. Aratana Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Animal Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Companion Animal Drugs Market Share by Type: 2023 VS 2030
Figure 3. Antibiotics and Antimicrobials Features
Figure 4. Parasiticides Features
Figure 5. Others Features
Figure 6. Global Companion Animal Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Companion Animal Drugs Market Share by Application: 2023 VS 2030
Figure 8. Dogs Case Studies
Figure 9. Cats Case Studies
Figure 10. Horses Case Studies
Figure 11. Others Case Studies
Figure 12. Companion Animal Drugs Report Years Considered
Figure 13. Global Companion Animal Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Companion Animal Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Companion Animal Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Companion Animal Drugs Market Share by Players in 2023
Figure 17. Global Top Companion Animal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Animal Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Companion Animal Drugs Revenue in 2023
Figure 19. North America Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Companion Animal Drugs Market Share by Country (2019-2030)
Figure 21. United States Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Companion Animal Drugs Market Share by Country (2019-2030)
Figure 25. Germany Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Companion Animal Drugs Market Share by Region (2019-2030)
Figure 33. China Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Companion Animal Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Companion Animal Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Companion Animal Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Zoetis Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 48. Bayer Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 50. Eli Lilly Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 52. Vetoquinol Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 53. Virbac Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 54. Dechra Pharmaceuticals Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 55. Ceva Sante Animale Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 56. Aratana Therapeutics Revenue Growth Rate in Companion Animal Drugs Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232